Literature DB >> 20819953

Regulation of cAMP-dependent protein kinases: the human protein kinase X (PrKX) reveals the role of the catalytic subunit alphaH-alphaI loop.

Mandy Diskar1, Hans-Michael Zenn, Alexandra Kaupisch, Melanie Kaufholz, Stefanie Brockmeyer, Daniel Sohmen, Marco Berrera, Manuela Zaccolo, Michael Boshart, Friedrich W Herberg, Anke Prinz.   

Abstract

cAMP-dependent protein kinases are reversibly complexed with any of the four isoforms of regulatory (R) subunits, which contain either a substrate or a pseudosubstrate autoinhibitory domain. The human protein kinase X (PrKX) is an exemption as it is inhibited only by pseudosubstrate inhibitors, i.e. RIα or RIβ but not by substrate inhibitors RIIα or RIIβ. Detailed examination of the capacity of five PrKX-like kinases ranging from human to protozoa (Trypanosoma brucei) to form holoenzymes with human R subunits in living cells shows that this preference for pseudosubstrate inhibitors is evolutionarily conserved. To elucidate the molecular basis of this inhibitory pattern, we applied bioluminescence resonance energy transfer and surface plasmon resonance in combination with site-directed mutagenesis. We observed that the conserved αH-αI loop residue Arg-283 in PrKX is crucial for its RI over RII preference, as a R283L mutant was able to form a holoenzyme complex with wild type RII subunits. Changing the corresponding αH-αI loop residue in PKA Cα (L277R), significantly destabilized holoenzyme complexes in vitro, as cAMP-mediated holoenzyme activation was facilitated by a factor of 2-4, and lead to a decreased affinity of the mutant C subunit for R subunits, significantly affecting RII containing holoenzymes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819953      PMCID: PMC2975214          DOI: 10.1074/jbc.M110.155150

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Force fields for protein simulations.

Authors:  Jay W Ponder; David A Case
Journal:  Adv Protein Chem       Date:  2003

2.  Molecular simulation of the binding of nerve growth factor peptide mimics to the receptor tyrosine kinase A.

Authors:  Marco Berrera; Antonino Cattaneo; Paolo Carloni
Journal:  Biophys J       Date:  2006-06-23       Impact factor: 4.033

3.  Molecular forms and subunit composition of a cyclic adenosine 3',5'-monophosphate-dependent protein kinase purified from bovine heart muscle.

Authors:  C S Rubin; J Erlichman; O M Rosen
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

4.  Catabolite activator protein in aqueous solution: a molecular simulation study.

Authors:  Marco Berrera; Sergio Pantano; Paolo Carloni
Journal:  J Phys Chem B       Date:  2007-01-23       Impact factor: 2.991

5.  Profiles of PrKX expression in developmental mouse embryo and human tissues.

Authors:  Wei Li; Zu-Xi Yu; Robert M Kotin
Journal:  J Histochem Cytochem       Date:  2005-05-06       Impact factor: 2.479

6.  Swiss Cheese, a protein involved in progressive neurodegeneration, acts as a noncanonical regulatory subunit for PKA-C3.

Authors:  Alexandre Bettencourt da Cruz; Jill Wentzell; Doris Kretzschmar
Journal:  J Neurosci       Date:  2008-10-22       Impact factor: 6.167

7.  Molecular basis for isoform-specific autoregulation of protein kinase A.

Authors:  Mandy Diskar; Hans-Michael Zenn; Alexandra Kaupisch; Anke Prinz; Friedrich W Herberg
Journal:  Cell Signal       Date:  2007-06-09       Impact factor: 4.315

8.  PRKX, a phylogenetically and functionally distinct cAMP-dependent protein kinase, activates renal epithelial cell migration and morphogenesis.

Authors:  Xiaohong Li; Hsi-Ping Li; Kurt Amsler; Deborah Hyink; Patricia D Wilson; Christopher R Burrow
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

9.  Novel isoform-specific interfaces revealed by PKA RIIbeta holoenzyme structures.

Authors:  Simon H J Brown; Jian Wu; Choel Kim; Kimberly Alberto; Susan S Taylor
Journal:  J Mol Biol       Date:  2009-09-11       Impact factor: 5.469

10.  Genomic analysis of the eukaryotic protein kinase superfamily: a perspective.

Authors:  Steven K Hanks
Journal:  Genome Biol       Date:  2003-04-29       Impact factor: 13.583

View more
  6 in total

1.  A conserved Glu-Arg salt bridge connects coevolved motifs that define the eukaryotic protein kinase fold.

Authors:  Jie Yang; Jian Wu; Jon M Steichen; Alexandr P Kornev; Michael S Deal; Sheng Li; Banumathi Sankaran; Virgil L Woods; Susan S Taylor
Journal:  J Mol Biol       Date:  2011-11-25       Impact factor: 5.469

2.  Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag.

Authors:  Oleg G Chepurny; Daniela Bertinetti; Mandy Diskar; Colin A Leech; Parisa Afshari; Tamara Tsalkova; Xiaodong Cheng; Frank Schwede; Hans-G Genieser; Friedrich W Herberg; George G Holz
Journal:  Mol Endocrinol       Date:  2013-06-24

Review 3.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

4.  Human heart failure is accompanied by altered protein kinase A subunit expression and post-translational state.

Authors:  Young Soo Han; Jennifer Arroyo; Ozgur Ogut
Journal:  Arch Biochem Biophys       Date:  2013-08-11       Impact factor: 4.013

Review 5.  Exploring the Plasmodium falciparum cyclic-adenosine monophosphate (cAMP)-dependent protein kinase (PfPKA) as a therapeutic target.

Authors:  Nina M Haste; Hana Talabani; Alex Doo; Anais Merckx; Gordon Langsley; Susan S Taylor
Journal:  Microbes Infect       Date:  2012-05-22       Impact factor: 2.700

6.  Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas.

Authors:  Isabel Weigand; Cristina L Ronchi; Marthe Rizk-Rabin; Guido Di Dalmazi; Vanessa Wild; Kerstin Bathon; Beatrice Rubin; Davide Calebiro; Felix Beuschlein; Jérôme Bertherat; Martin Fassnacht; Silviu Sbiera
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.